10.07.2015 Views

Clinical Guidelines for the Safe Use of McKinley T34 Syringe Pump

Clinical Guidelines for the Safe Use of McKinley T34 Syringe Pump

Clinical Guidelines for the Safe Use of McKinley T34 Syringe Pump

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

As such, <strong>the</strong> main aim <strong>of</strong> <strong>the</strong>se guidelines is to assist health care pr<strong>of</strong>essionals administeringdrugs via <strong>the</strong> <strong>McKinley</strong> <strong>T34</strong> <strong>Syringe</strong> <strong>Pump</strong> and to promote a procedural uni<strong>for</strong>mity across Halton& St Helens Primary Care Trust.To this end, <strong>the</strong>se guidelines also aim to:I. Introduce and establish rigorous procedures to ensure a consistent approach to <strong>the</strong> use <strong>of</strong><strong>the</strong> <strong>McKinley</strong> <strong>T34</strong> <strong>Syringe</strong> <strong>Pump</strong>.II. Reduce <strong>the</strong> potential risk <strong>of</strong> adverse incidents (Medical Devices Agency Device Bulletin2003(02)).III. Improve patient safety and clinical outcomes.IV. Provide evidence <strong>for</strong> <strong>the</strong> organisation to meet <strong>the</strong> Standards <strong>for</strong> Better HealthV. Establish key per<strong>for</strong>mance indicators to monitor and evaluate <strong>the</strong> effectiveness <strong>of</strong> <strong>the</strong>guidanceThis document should be read in conjunction with <strong>the</strong> Policy <strong>for</strong> administration <strong>of</strong> ControlledDrugs, Decontamination Policy Infection Prevention and Control Policy and <strong>the</strong> End <strong>of</strong> Life CarePathway.DEFINITIONSThe <strong>McKinley</strong> <strong>T34</strong> syringe pump is a portable battery-operated infusion pump weighingapproximately 210g (excluding <strong>the</strong> battery) and measuring 169mm by 53mm by 23mm. It isused <strong>for</strong> <strong>the</strong> administration <strong>of</strong> medication subcutaneously over a 24 hour period.DUTIES, ROLES AND RESPONSIBILITESAuthor(s) are responsible <strong>for</strong> ensuring that:a) Once ratified, <strong>the</strong> clinical guideline is maintained in an editable electronic version (mastercopy).b) An Impact Assessment has been completed <strong>for</strong> <strong>the</strong> document and submitted to <strong>the</strong> Head<strong>of</strong> Corporate Services and Business.c) The responsible committee or <strong>of</strong>ficers are alerted <strong>of</strong> any necessary review to beundertaken.d) All amendments are completed subsequent to <strong>the</strong> findings <strong>of</strong> any review.Responsible Committee or Officers are responsible <strong>for</strong>:a) Undertaking any review <strong>of</strong> <strong>the</strong> document: In response to any recommendation(s) madefollowing an audit <strong>of</strong> <strong>the</strong> document. In line with <strong>the</strong> agreed review date (a maximum <strong>of</strong>Page 6 <strong>of</strong> 33

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!